MRT3-007

N/A

Report date: 2025/01/26 15:38:15
NME

Base Information

Drug NameMRT3-007
Drug Alias NameCDK5 inhibitor (Manros Therapeutics/University Of Alabama at Birmingham/St Vincents Institute/University Of Florida)MRT3-007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 5 degraders
TargetsCyclin-dependent kinase 5
Therapy Area/IndicationsPheochromocytoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New ZealandFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesManros Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesSt Vincent's Institute Medical ResearchUniversity Of FloridaUniversity Of Alabama At Birmingham +[4] 
Inactive CompaniesN/A
Active IndicationsPheochromocytoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A